Walleye Capital
PYXS icon

Walleye Capital’s Pyxis Oncology PYXS Stock Holding History

Walleye Capital’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$111K Buy
+36,778
New +$70.3K ﹤0.01% 3847
2025
Q4 		– Sell
-119,561
Closed -$265K – 5008
2025
Q3 		$265K Buy
+119,561
New +$172K ﹤0.01% 3116
2022
Q1 		– Sell
-15,933
Closed -$175K – 2534
2021
Q4 		$175K Buy
+15,933
New +$182K 0.01% 1520

Other funds holding PYXS

GGI
GordonMD Global Investments Beverely Hills, California $207M AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Walleye Capital's PYXS Position: Q2 2026 in Review

Walleye Capital opened a new position in Pyxis Oncology (PYXS) in Q2 2026: 36,778 shares worth $111K. The stake represents ﹤0.01% of the portfolio and ranks #3847 among its holdings. This is a return to the name: Walleye Capital previously reported a position in PYXS as recently as Q3 2025.

Walleye Capital first reported a position in PYXS in Q4 2021 and has held it in 3 quarters since. The position peaked at $265K in Q3 2025. 76 funds tracked by Wall St. Rank hold PYXS as of Q2 2026.

  • Walleye Capital held 36,778 shares of Pyxis Oncology worth $111K as of Q2 2026.
  • Pyxis Oncology was a new Walleye Capital position in Q2 2026.
  • Pyxis Oncology made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #3847 holding.
  • Walleye Capital first reported a position in Pyxis Oncology in Q4 2021 and has held it in 3 quarters since.
  • Walleye Capital's Pyxis Oncology position peaked at $265K in Q3 2025.
  • 76 funds tracked by Wall St. Rank held Pyxis Oncology as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.